Fig. 2From: Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-upSurvival without new-onset diabetes in the pitavastatin 1 mg and pitavastatin 4 mg groups during the 3-year follow-upBack to article page